← The Wire
NBIXNasdaq
NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · DE · CIK 914475
Neurocrine Biosciences discovers, develops, and commercializes treatments for neurological, psychiatric, endocrine, and immunological disorders
red 8-K · 90d
$16.06B
Market cap
$170.00
Last close
+0.9%
1D
+5.2%
5D
1.4M
Volume
Price · last 39 sessions+26.8%
May 4L $134.07 · H $170.00Jun 29
159
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 28, 20268-KMaterial Agreement · Acquisition / DispositionMay 18, 20268-KResults of OperationsMay 5, 20268-KMaterial AgreementApr 6, 20268-KResults of OperationsFeb 11, 20268-KExecutive ChangeNov 24, 20258-KResults of OperationsOct 28, 20258-KResults of OperationsJul 30, 20258-KExecutive ChangeMay 30, 20258-KExecutive Change · Shareholder VoteMay 22, 20258-KResults of OperationsMay 5, 20258-KExecutive Change · Reg FD DisclosureApr 4, 20258-KResults of OperationsFeb 6, 20258-KMaterial Agreement · Reg FD DisclosureJan 27, 20258-KCompany UpdateDec 20, 20248-KCompany UpdateNov 1, 20248-KResults of OperationsOct 30, 20248-KExecutive ChangeOct 11, 20248-KReg FD Disclosure · Company UpdateAug 28, 20248-KResults of OperationsAug 1, 20248-KExecutive Change · Bylaw AmendmentMay 28, 20248-KExecutive Change · Shareholder VoteMay 23, 20248-KResults of OperationsMay 1, 20248-KResults of OperationsFeb 7, 20248-KCompany UpdateNov 13, 20238-KCompany UpdateNov 9, 20238-KResults of OperationsOct 31, 20238-KCompany UpdateOct 6, 20238-KCompany UpdateOct 5, 20238-KCompany UpdateSep 12, 20238-KResults of OperationsAug 1, 20238-KExecutive ChangeJul 13, 20238-KExecutive Change · Bylaw AmendmentJul 12, 20238-KExecutive Change · Shareholder VoteMay 19, 20238-KResults of OperationsMay 3, 20238-KCompany UpdateMar 29, 20238-KCompany UpdateFeb 24, 20238-KBylaw AmendmentFeb 10, 20238-KResults of OperationsFeb 6, 20238-KMaterial AgreementJan 9, 20238-KResults of OperationsNov 1, 20228-KReg FD DisclosureAug 30, 20228-KResults of OperationsAug 4, 20228-KCompany UpdateJun 1, 20228-KCompany UpdateMay 25, 20228-KExecutive Change · Shareholder VoteMay 23, 20228-KResults of OperationsMay 4, 20228-KResults of OperationsFeb 11, 20228-KResults of OperationsJan 6, 20228-KCompany UpdateDec 23, 20218-KMaterial AgreementNov 22, 20218-KResults of OperationsNov 1, 20218-KResults of OperationsAug 3, 20218-KShareholder VoteMay 21, 20218-KResults of OperationsMay 5, 20218-KExecutive Change · Bylaw AmendmentApr 16, 20218-KResults of OperationsFeb 4, 20218-KCompany UpdateFeb 2, 20218-KResults of OperationsJan 8, 20218-KCompany UpdateNov 24, 20208-KCompany UpdateNov 19, 20208-KResults of OperationsNov 9, 20208-KReg FD DisclosureSep 10, 20208-KBylaw AmendmentAug 28, 20208-KCompany UpdateAug 3, 20208-KCompany UpdateJul 28, 20208-KCompany UpdateJul 13, 20208-KMaterial AgreementJun 16, 20208-KExecutive Change · Shareholder VoteMay 21, 20208-KResults of OperationsMay 6, 20208-KExecutive ChangeApr 9, 20208-KResults of OperationsFeb 5, 20208-KExecutive Change · Results of OperationsFeb 4, 20208-KResults of OperationsJan 13, 20208-KResults of OperationsNov 4, 20198-KExecutive ChangeSep 11, 20198-KResults of OperationsJul 29, 20198-KExecutive Change · Shareholder VoteMay 23, 20198-KResults of OperationsApr 29, 20198-KReg FD DisclosureApr 26, 2019
Insider Activity
In the 90 days to Jan 16, 2026: 7 sold $14.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 34,588 | $132.70 | $4.6M |
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 1,812 | $132.71 | $240K |
| Dec 16, 2025 | Norwalk Leslie VDirector | Sell | 1,190 | $155.09 | $185K |
| Dec 15, 2025 | Norwalk Leslie VDirector | Sell | 5,000 | $152.23 | $761K |
| Dec 8, 2025 | Lippoldt DarinChief Legal Officer | Sell | 4,376 | $159.65 | $699K |
| Dec 3, 2025 | Lyons Gary ADirector | Sell | 15,000 | $152.61 | $2.3M |
| Nov 28, 2025 | Benevich EricChief Commercial Officer | Sell | 5,970 | $151.74 | $906K |
| Nov 25, 2025 | Morrow George JDirector | Sell | 15,000 | $143.37 | $2.2M |
| Nov 5, 2025 | Rastetter William HDirector | Sell | 18,000 | $151.82 | $2.7M |
| Nov 4, 2025 | Gano KyleChief Executive Officer | Sell | 300 | $141.97 | $43K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance